{"member_organisations": "ITCC gather more than 50 centres  \nhttp://www.itcc-consortium.org/itcc-accreditation-quality-committee.php", "identification_number": "193382825960-65", "fields_of_interest": "Public Health", "head_office_address": "Innovative Therapies for Children with Cancer 114 rue Edouard Vaillant", "full_time_equivalent_fte": "2,25", "person_with_legal_responsibility": "Gilles Vassal", "industry_forums": "", "grants": "", "inter_groups": "", "eu_initiatives": "ITCC is a founding member of the Accelerate Platform (http://www.accelerate-platform.eu/) aiming at accelerating innovation for children and adolescents with cancer \n \nThe purpose of the ACCELERATE platform is to provide a transparent forum for patients and parents organisations, academic paediatric oncologists and haematologists, pharmaceutical companies and EU regulatory network representatives to discuss, explain and seek ways to address specific overarching issues in promoting to timely improve the outcome of children and adolescents with cancer through the development of innovative anticancer medicines in a timely fashion.", "level_of_interest": "European", "organisation_name": "Innovative Therapies for Children with Cancer (ITCC)", "belgium_office_post_code": "", "number_of_persons_involved": "3", "person_in_charge_of_eu_relations": "Gilles Vassal", "section": "III - Non-governmental organisations", "source": "", "subsection": "Non-governmental organisations, platforms and networks and similar", "belgium_office_phone": "", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "", "no_geo_reference": true, "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "09/03/2017", "estimate_of_costs_absolute_amount": "0", "website_address": "http://www.itcc-consortium.org/", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Villejuif", "membership": "http://www.accelerate-platform.eu/ \nhttps://www.siope.eu/", "head_office_post_code": "94805", "position": "Pr\u00e9sident", "financial_year_start_date": "01/01/2017", "head_office_country": "France", "number_of_ep_accredited_persons": "", "relevant_communication": "", "financial_year_end_date": "01/12/2017", "estimate_of_costs_as_a_range": "", "overall_budget_turnover_absolute_amount": "150000", "legal_status": "Association loi 1901", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "ITCC gathers 51 European Paediatric Oncology Departments with expertise in conducting early phase trials in children and adolescents, and 9 European research laboratories. \nThe aim of this organisation is to develop novel therapies for the treatment of paediatric and adolescent cancers in cooperation with regulatory bodies, pharmaceutical enterprises, parents and patients. \n  \nIn January 2011 ITCC was established as a European Category 1 Network for Paediatric Research at the European Medicines Agency (EnprEMA). \nIts structure comprises several Committees which take care and contribute to a particular issue in the development of novel therapeutic strategies in paediatric oncology", "belgium_office_city": "", "head_office_phone": "(+33)142116033"}